07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

Idexx, Barnes-Jewish Hospital agbio/veterinary/environmental news

The parties settled a patent infringement suit brought by Barnes-Jewish Hospital in May 1995 in the U.S. District Court for the District of Maine alleging that IDXX was infringing U.S. Patent No. 4,839,275 covering methods...
01:06 , Sep 21, 2005 |  BC Extra  |  Financial News

Kereos raises $19.5 million

Kereos (St. Louis, Mo.) raised $19.5 million in a series B round led by new investors Prolog Ventures; Triathlon; Charter Life Sciences; and existing investor RiverVest Venture Partners. Existing investor Barnes-Jewish Hospital and new investors...
07:00 , Jun 28, 2004 |  BioCentury  |  Emerging Company Profile

Kereos: Seek AND destroy

While most companies are satisfied with pursuing compounds that either diagnose or treat an ailment, Kereos has set out to accomplish both, using pairs of targeted imaging and therapeutic agents. With help from corporate and...
07:00 , Aug 3, 1998 |  BC Week In Review  |  Company News

Synbiotics, Barnes-Jewish Hospital agbio/veterinary/environmental news

The parties settled patent litigation related to the company's canine heartworm diagnostic products (see BioCentury Oct. 20, 1997). Under the settlement, SBIO obtained a license to the hospital's U.S., Canadian and Australian patents for applicable...
07:00 , Oct 20, 1997 |  BC Week In Review  |  Company News

Synbiotics, Barnes-Jewish Hospital agbio/veterinary/environmental news

Barnes-Jewish sued the company in the U.S. District Court for the Eastern District of Missouri, alleging that SBIO infringes U.S. Patent No. 4,839,275, which covers methods and compositions to diagnose canine heartworm infection. SBIO said...